Healthcare provider profile · identity verified

John R Gosling, MD

Internal Medicine · SAINT JOSEPH, MI · NPI 1851387302

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	914	292
Losartan Potassium	Losartan Potassium	675	203
Amlodipine Besylate	Amlodipine Besylate	634	190
Levothyroxine Sodium	Levothyroxine Sodium	467	130
Omeprazole	Omeprazole	414	138
Simvastatin	Simvastatin	268	73
Metoprolol Succinate	Metoprolol Succinate	258	79
Lisinopril	Lisinopril	240	78
Tamsulosin Hcl	Tamsulosin Hcl	236	73
Pravastatin Sodium	Pravastatin Sodium	225	64
Hydrochlorothiazide	Hydrochlorothiazide	205	63
Metformin Hcl	Metformin Hcl	204	67
Pantoprazole Sodium	Pantoprazole Sodium	204	59
Rosuvastatin Calcium	Rosuvastatin Calcium	187	59
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	185	48
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	180	46
Alprazolam	Alprazolam	155	44
Metformin Hcl Er	Metformin Hcl	151	47
Duloxetine Hcl	Duloxetine Hcl	142	42
Allopurinol	Allopurinol	140	39
Tramadol Hcl	Tramadol Hcl	140	47
Sertraline Hcl	Sertraline Hcl	118	43
Montelukast Sodium	Montelukast Sodium	115	40
Irbesartan	Irbesartan	113	36
Furosemide	Furosemide	103	35
Gabapentin	Gabapentin	101	41
Chlorthalidone	Chlorthalidone	100	35
Meloxicam	Meloxicam	99	40
Eliquis	Apixaban	98	32
Metoprolol Tartrate	Metoprolol Tartrate	94	35
Fluticasone Propionate	Fluticasone Propionate	91	39
Carvedilol	Carvedilol	86	28
Zolpidem Tartrate	Zolpidem Tartrate	82	28
Alendronate Sodium	Alendronate Sodium	79	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	77	25
Trazodone Hcl	Trazodone Hcl	76	24
Lorazepam	Lorazepam	73	13
Diclofenac Sodium	Diclofenac Sodium	70	25
Donepezil Hcl	Donepezil Hcl	69	19
Clopidogrel	Clopidogrel Bisulfate	66	21
Albuterol Sulfate Hfa	Albuterol Sulfate	58	22
Potassium Chloride	Potassium Chloride	58	18
Fluoxetine Hcl	Fluoxetine Hcl	56	20
Mirtazapine	Mirtazapine	56	21
Atenolol	Atenolol	55	16
Olmesartan Medoxomil	Olmesartan Medoxomil	49	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	49	15
Bupropion Xl	Bupropion Hcl	47	15
Finasteride	Finasteride	45	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	43	14
Jardiance	Empagliflozin	39	14
Oxybutynin Chloride Er	Oxybutynin Chloride	39	11
Warfarin Sodium	Warfarin Sodium	39	12
Januvia	Sitagliptin Phosphate	38	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	12
Prednisone	Prednisone	38	28
Xarelto	Rivaroxaban	38	11
Ozempic	Semaglutide	37	suppressed
Benazepril Hcl	Benazepril Hcl	36	suppressed
Lovastatin	Lovastatin	36	11
Ezetimibe	Ezetimibe	35	suppressed
Glimepiride	Glimepiride	35	12
Tizanidine Hcl	Tizanidine Hcl	35	suppressed
Cephalexin	Cephalexin	34	26
Citalopram Hbr	Citalopram Hydrobromide	34	14
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Nadolol	Nadolol	32	suppressed
Torsemide	Torsemide	30	11
Farxiga	Dapagliflozin Propanediol	29	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	suppressed
Spironolactone	Spironolactone	29	12
Triamcinolone Acetonide	Triamcinolone Acetonide	29	19
Clonazepam	Clonazepam	28	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Famotidine	Famotidine	27	suppressed
Meclizine Hcl	Meclizine Hcl	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Glipizide	Glipizide	26	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	21
Dexamethasone	Dexamethasone	25	24
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	25	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	25	suppressed
Hydralazine Hcl	Hydralazine Hcl	24	suppressed
Mounjaro	Tirzepatide	24	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Celecoxib	Celecoxib	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	13
Hydrocortisone	Hydrocortisone	21	suppressed
Ipratropium Bromide	Ipratropium Bromide	21	suppressed
Diazepam	Diazepam	20	suppressed
Naproxen	Naproxen	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	13
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	11
Pregabalin	Pregabalin	19	suppressed
Temazepam	Temazepam	19	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Verapamil Er	Verapamil Hcl	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	16	suppressed
Rizatriptan	Rizatriptan Benzoate	16	suppressed
Topiramate	Topiramate	16	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Metolazone	Metolazone	15	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	13
Memantine Hcl	Memantine Hcl	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Methylphenidate Er	Methylphenidate Hcl	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Estradiol	Estradiol	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Digoxin	Digoxin	11	suppressed
Tradjenta	Linagliptin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error